IDEXX Laboratories, Inc. Stock
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
504 USD | -0.42% | +1.30% | -9.20% |
May. 29 | Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM | |
May. 14 | Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620 | MT |
Financials (USD)
Sales 2024 * | 3.94B | Sales 2025 * | 4.34B | Capitalization | 41.62B |
---|---|---|---|---|---|
Net income 2024 * | 922M | Net income 2025 * | 1.04B | EV / Sales 2024 * | 10.7 x |
Net Debt 2024 * | 396M | Net Debt 2025 * | 223M | EV / Sales 2025 * | 9.65 x |
P/E ratio 2024 * |
45.5
x | P/E ratio 2025 * |
40.3
x | Employees | 11,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.19% |
Latest transcript on IDEXX Laboratories, Inc.
1 day | -0.42% | ||
1 week | +1.30% | ||
Current month | +1.42% | ||
1 month | -3.28% | ||
3 months | -5.90% | ||
6 months | -9.05% | ||
Current year | -9.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 12-07-31 | |
Brian McKeon
DFI | Director of Finance/CFO | 61 | 03-06-30 |
John Hart
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 14-03-10 |
M. Szostak
BRD | Director/Board Member | 73 | 12-07-15 |
Chairman | 61 | 16-10-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.32% | 1 M€ | -.--% | ||
1.59% | 21 M€ | +8.79% | - | |
1.14% | 2 M€ | -1.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 504 | -0.42% | 386,651 |
24-06-13 | 506.1 | -1.59% | 463,045 |
24-06-12 | 514.3 | +1.60% | 414,196 |
24-06-11 | 506.2 | -0.41% | 348,758 |
24-06-10 | 508.3 | +2.16% | 565,122 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- IDXX Stock